Serum  	Serum  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
status  	status  	 NN	I-NP
in  	in  	 IN	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
disease  	disease  	 NN	O
with  	with  	 IN	O
and  	and  	 CC	O
without  	without  	 IN	O
orbitopathy 	orbitopathy 	 NNS	B-NP
:  	:  	 :	O
a  	a  	 DT	O
case-control  	case-control  	 JJ	B-NP
study  	study  	 NN	I-NP
Selenium  	Selenium  	 NNP	I-NP
is  	is  	 VBZ	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
improving  	improving  	 VBG	B-NP
quality  	quality  	 NN	I-NP
of  	of  	 IN	O
life  	life  	 NN	O
and  	and  	 CC	O
reducing  	reducing  	 VBG	O
the  	the  	 DT	O
progression  	progression  	 NN	O
of  	of  	 IN	O
active  	active  	 JJ	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
orbitopathy 	orbitopathy 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
correcting  	correcting  	 VBG	O
relative  	relative  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
deficiency  	deficiency  	 NN	I-NP
on  	on  	 IN	O
improving  	improving  	 VBG	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
orbitopathy  	orbitopathy  	 NN	B-NP
is  	is  	 VBZ	O
unknown 	unknown 	 JJ	O
,  	,  	 ,	O
as  	as  	 IN	O
baseline  	baseline  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
have  	have  	 VBP	O
not  	not  	 RB	O
previously  	previously  	 RB	O
been  	been  	 VBN	O
measured 	measured 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
study  	study  	 NN	O
aims  	aims  	 VBZ	O
to  	to  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
serum  	serum  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
are  	are  	 VBP	O
reduced  	reduced  	 VBN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
disease  	disease  	 NN	O
with  	with  	 IN	O
orbitopathy  	orbitopathy  	 NNS	B-NP
( 	( 	 -LRB-	O
GO 	GO 	 NNP	O
)  	)  	 -RRB-	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
without  	without  	 IN	O
orbitopathy  	orbitopathy  	 NNS	B-NP
( 	( 	 -LRB-	O
GD 	GD 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
prospective 	prospective 	 JJ	O
,  	,  	 ,	O
case-control  	case-control  	 JJ	B-NP
study  	study  	 NN	I-NP
performed  	performed  	 VBN	O
between  	between  	 IN	O
2009  	2009  	 CD	O
and  	and  	 CC	O
2012  	2012  	 CD	O
at  	at  	 IN	O
endocrine  	endocrine  	 NN	B-NP
and  	and  	 CC	O
ophthalmology  	ophthalmology  	 JJ	B-NP
clinics  	clinics  	 NNS	I-NP
in  	in  	 IN	O
Australia 	Australia 	 NNP	B-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
198  	198  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
disease  	disease  	 NN	O
participated  	participated  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
study 	study 	 NN	O
:  	:  	 :	O
101  	101  	 CD	O
with  	with  	 IN	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
orbitopathy  	orbitopathy  	 NN	B-NP
and  	and  	 CC	O
97  	97  	 CD	O
without  	without  	 IN	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
orbitopathy 	orbitopathy 	 NN	B-NP
.  	.  	 .	O
Serum  	Serum  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
both  	both  	 DT	O
groups 	groups 	 NNS	O
.  	.  	 .	O
Mean  	Mean  	 VB	O
serum  	serum  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
lower  	lower  	 JJR	O
in  	in  	 IN	O
GO  	GO  	 NNP	O
( 	( 	 -LRB-	O
1·10  	1·10  	 FW	O
±  	±  	 FW	O
0·18  	0·18  	 FW	O
μm 	μm 	 FW	B-NP
)  	)  	 -RRB-	O
than  	than  	 IN	O
in  	in  	 IN	O
GD  	GD  	 NNP	B-NP
( 	( 	 -LRB-	O
1·19  	1·19  	 FW	O
±  	±  	 FW	O
0·20  	0·20  	 FW	O
μm 	μm 	 FW	B-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·001 	0·001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mean  	Mean  	 VB	O
selenium  	selenium  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
appeared  	appeared  	 VBD	O
to  	to  	 TO	O
decrease  	decrease  	 VB	O
in  	in  	 IN	O
parallel  	parallel  	 NN	B-NP
with  	with  	 IN	O
increasing  	increasing  	 VBG	B-NP
severity  	severity  	 NN	I-NP
of  	of  	 IN	O
GO 	GO 	 NNP	O
;  	;  	 :	O
selenium  	selenium  	 JJ	B-NP
level  	level  	 NN	I-NP
was  	was  	 VBD	O
1·19  	1·19  	 CD	O
±  	±  	 CD	O
0·20  	0·20  	 CD	O
μm  	μm  	 NN	B-NP
in  	in  	 IN	O
GD 	GD 	 NNP	B-NP
,  	,  	 ,	O
1·10  	1·10  	 CD	O
±  	±  	 CD	O
0·19  	0·19  	 CD	O
μm  	μm  	 NN	B-NP
in  	in  	 IN	O
moderate-to-severe  	moderate-to-severe  	 NNP	B-NP
GO  	GO  	 NNP	I-NP
and  	and  	 CC	O
1·09  	1·09  	 CD	O
±  	±  	 CD	O
0·17  	0·17  	 CD	O
μm  	μm  	 NN	B-NP
in  	in  	 IN	O
sight-threatening  	sight-threatening  	 NNP	O
GO  	GO  	 NNP	O
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·003 	0·003 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Serum  	Serum  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
remained  	remained  	 VBD	O
significantly  	significantly  	 RB	O
lower  	lower  	 JJR	O
in  	in  	 IN	O
GO  	GO  	 NNP	O
after  	after  	 IN	O
adjusting  	adjusting  	 VBG	O
for  	for  	 IN	O
age 	age 	 NN	O
,  	,  	 ,	O
smoking  	smoking  	 NN	O
status 	status 	 NN	O
,  	,  	 ,	O
thyroidectomy 	thyroidectomy 	 NN	B-NP
,  	,  	 ,	O
radioactive  	radioactive  	 JJ	B-NP
iodine  	iodine  	 JJ	I-NP
treatment  	treatment  	 NN	I-NP
and  	and  	 CC	O
residential  	residential  	 JJ	B-NP
location 	location 	 NN	I-NP
.  	.  	 .	O
Serum  	Serum  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
are  	are  	 VBP	O
lower  	lower  	 JJR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
GO  	GO  	 NNP	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
GD  	GD  	 NNP	B-NP
in  	in  	 IN	O
an  	an  	 DT	O
Australian  	Australian  	 JJ	O
study  	study  	 NN	B-NP
population  	population  	 NN	I-NP
with  	with  	 IN	O
marginal  	marginal  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
status 	status 	 NN	I-NP
.  	.  	 .	O
Relative  	Relative  	 JJ	B-NP
selenium  	selenium  	 JJ	I-NP
deficiency  	deficiency  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
an  	an  	 DT	O
independent  	independent  	 JJ	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
for  	for  	 IN	I-NP
orbitopathy  	orbitopathy  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
Graves 	Graves 	 NNP	O
'  	'  	 POS	O
disease 	disease 	 NN	O
.  	.  	 .	O
